Comparative efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or in addition to chemotherapy for advanced, PD-L1 high non-small cell lung cancer (NSCLC): A meta-analysis of randomized trials

被引：0
|
作者：
Di Federico, A. [1 ]
De Giglio, A. [1 ]
Nuvola, G. [1 ]
Deiana, C. [1 ]
Conci, N. [1 ]
Bonucci, C. [1 ]
Donati, G. [1 ]
Parisi, C. [1 ]
Gelsomino, F. [2 ]
Ardizzoni, A. [2 ]
机构：
[1] Univ Bologna, Dept Specialized Expt & Diagnost Med, Bologna, Italy
[2] IRCCS Azienda Osped Univ Bologna, Div Med Oncol, Bologna, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113P
引用
收藏
页码：S759 / S759
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials
    Li, Xiang
    Yan, Shi
    Yang, Jichun
    Wang, Yaqi
    Lv, Chao
    Li, Shaolei
    Zhao, Jun
    Yang, Yue
    Zhuo, Minglei
    Wu, Nan
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [2] Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC)
    Gonzalez-Velez, Abel
    Pino-Villareal, Luis E.
    Barrera-Barinas, Alexander
    Castillo-Niuman, Andrea
    Tolosa-Perez, Erica N.
    Castelblanco, Diana, I
    Pinzon-Florez, Carlos E.
    Yomayusa, Nancy
    GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03): : 111 - 123
  • [3] Comparative efficacy and safety of PD-1/PD-L1 immunotherapies for non-small cell lung cancer: a network meta-analysis
    Wang, D-D
    Shaver, L. G.
    Shi, F-Y
    Wei, J-J
    Qin, T-Z
    Wang, S-Z
    Kong, Y. J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2866 - 2884
  • [4] Efficacy of PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer: A meta-analysis of randomized clinical trials
    Peng, Tzu-Rong
    Wu, Ta-Wei
    THORACIC CANCER, 2019, 10 (05) : 1176 - 1181
  • [5] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [6] Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
    Luo, Wenxin
    Wang, Zhoufeng
    Tian, Panwen
    Li, Weimin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (10) : 1851 - 1859
  • [7] Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
    Wenxin Luo
    Zhoufeng Wang
    Panwen Tian
    Weimin Li
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1851 - 1859
  • [8] PD-1/PD-L1 inhibitors in treatment-naive, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials
    Wankhede, Durgesh
    Hofman, Paul
    Grover, Sandeep
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 2179 - 2189
  • [9] PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials
    Durgesh Wankhede
    Paul Hofman
    Sandeep Grover
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2179 - 2189
  • [10] Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials
    Wang, Zhenzi
    Liu, Yuan
    Wang, Kedi
    Ma, Liyan
    BMC GASTROENTEROLOGY, 2024, 24 (01)
12345